{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:15:00Z","timestamp":1792120500464,"version":"4.4.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,1]]},"abstract":"<jats:p>It is suggested that the maternal transmission of islet autoantibodies increases the risk of autoimmune diabetes in mice. The aim of this study was to determine whether fetal exposure to islet autoantibodies modified the risk of type 1 diabetes in humans. Islet autoantibodies were measured at birth in 720 offspring of mothers with type 1 diabetes. Offspring were prospectively followed for the development of multiple islet autoantibodies and diabetes. Offspring who were GAD or IA-2 autoantibody positive at birth (n = 678) had significantly lower risks for developing multiple islet autoantibodies (5-year risk 1.3%) and diabetes (8-year risk 1.1%) than offspring who were islet autoantibody negative at birth (5.3%, P = 0.008; and 3%, P = 0.04, respectively). Risk remained reduced after adjustment for birth weight, gestational age, or maternal diabetes duration (adjusted hazards ratio 0.25, P = 0.007 for multiple islet autoantibodies; 0.25, P = 0.04 for diabetes). Protection in offspring with islet autoantibodies at birth was most striking in offspring without the HLA DRB1*03\/DRB1*04-DQB1*0302 genotype. Maternal transmission of antibodies to exogenous insulin did not affect diabetes risk in offspring. These findings suggest that fetal exposure to islet autoantibodies in children born to mothers with type 1 diabetes may be protective against future islet autoimmunity and diabetes.<\/jats:p>","DOI":"10.2337\/diabetes.53.1.1","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":97,"title":["Transmission of Maternal Islet Antibodies and Risk of Autoimmune Diabetes in Offspring of Mothers With Type 1 Diabetes"],"prefix":"10.2337","volume":"53","author":[{"given":"Kerstin","family":"Koczwara","sequence":"first","affiliation":[{"name":"Diabetes Research Institute and 3rd Medical Department, Krankenhaus Mu\u0308nchen-Schwabing, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Bonifacio","sequence":"additional","affiliation":[{"name":"Istituto Scientifico San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette-Gabriele","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute and 3rd Medical Department, Krankenhaus Mu\u0308nchen-Schwabing, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031207372006600_R1","doi-asserted-by":"crossref","unstructured":"Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Hummel M, Mollenhauer U, Vordemann J, Lenz A, Standl E: On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia\u200836: 402\u2013408,1993","DOI":"10.1007\/BF00402275"},{"key":"2022031207372006600_R2","doi-asserted-by":"crossref","unstructured":"Roll U, Christie MR, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG: Perinatal autoimmunity in offspring of diabetic parents: the German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes\u200845: 967\u2013973,1996","DOI":"10.2337\/diabetes.45.7.967"},{"key":"2022031207372006600_R3","doi-asserted-by":"crossref","unstructured":"Hamalainen AM, Ronkainen MS, Akerblom HK, Knip M: Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes: the Finnish TRIGR Study Group: Trial to Reduce IDDM in the Genetically at Risk. J Clin Endocrinol Metab\u200885: 4249\u20134253,2000","DOI":"10.1210\/jcem.85.11.6987"},{"key":"2022031207372006600_R4","doi-asserted-by":"crossref","unstructured":"Naserke HE, Bonifacio E, Ziegler AG: Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Endocrinol Metab\u200886: 4826\u20134833,2001","DOI":"10.1210\/jcem.86.10.7931"},{"key":"2022031207372006600_R5","doi-asserted-by":"crossref","unstructured":"Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H: Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med\u20088: 399\u2013402,2002","DOI":"10.1038\/nm0402-399"},{"key":"2022031207372006600_R6","doi-asserted-by":"crossref","unstructured":"von Herrath M, Bach JF: Juvenile autoimmune diabetes: a pathogenic role for maternal antibodies?Nat Med\u20088: 331\u2013333,2002","DOI":"10.1038\/nm0402-331"},{"key":"2022031207372006600_R7","doi-asserted-by":"crossref","unstructured":"Ziegler AG, Hummel M, Schenker M, Bonifacio E: Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes\u200848: 460\u2013468,1999","DOI":"10.2337\/diabetes.48.3.460"},{"key":"2022031207372006600_R8","doi-asserted-by":"crossref","unstructured":"Naserke HE, Bonifacio E, Ziegler AG: Immunoglobulin G insulin antibodies in BABYDIAB offspring appear postnatally: sensitive early detection using protein A\/G-based radiobinding assay. J Endocrinol Metab\u200884: 1239\u20131243,1999","DOI":"10.1210\/jc.84.4.1239"},{"key":"2022031207372006600_R9","doi-asserted-by":"crossref","unstructured":"Bingley PJ, Bonifacio E, Mueller PW: Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes\u200852: 1128\u20131136,2003","DOI":"10.2337\/diabetes.52.5.1128"},{"key":"2022031207372006600_R10","doi-asserted-by":"crossref","unstructured":"Walter M, Albert E, Conrad M, Keller E, Hummel M, Ferber K, Barratt BJ, Todd JA, Ziegler AG, Bonifacio E: IDDM2\/insulin VNTR modifies risk conferred by IDDM1\/HLA for development of type 1 diabetes and associated autoimmunity. Diabetologia\u200846: 712\u2013720,2003","DOI":"10.1007\/s00125-003-1082-z"},{"key":"2022031207372006600_R11","doi-asserted-by":"crossref","unstructured":"Manca F, Kunkl A, Fenoglio D, Fowler A, Sercarz E, Celada F: Constrains in T-B cooperation related to epitope topology on E. coli beta-galactosidase. I: the fine specificity of T cells dictates the fine specificity of antibodies directed to conformation-dependent determinants. Eur J Immunol\u200815: 345\u2013350,1985","DOI":"10.1002\/eji.1830150408"},{"key":"2022031207372006600_R12","doi-asserted-by":"crossref","unstructured":"Lin RH, Mamula MJ, Hardin JA, Janeway CA Jr: Induction of autoreactive B cells allows priming of autoreactive T cells. J Exp Med\u2008173: 1433\u20131439,1991","DOI":"10.1084\/jem.173.6.1433"},{"key":"2022031207372006600_R13","doi-asserted-by":"crossref","unstructured":"Watts C, Lanzavecchia A: Suppressive effect of antibody on processing of T cell epitopes. J Exp Med\u2008178: 1459\u20131463,1993","DOI":"10.1084\/jem.178.4.1459"},{"key":"2022031207372006600_R14","doi-asserted-by":"crossref","unstructured":"Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C: Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med\u2008181: 1957\u20131963,1995","DOI":"10.1084\/jem.181.6.1957"},{"key":"2022031207372006600_R15","doi-asserted-by":"crossref","unstructured":"Noorchashm H, Noorchashm N, Kern J, Rostami SY, Barker CF, Naji A: B-cells are required for the initiation of insulitis in nonobese diabetic mice. Diabetes\u200846: 941\u2013946,1997","DOI":"10.2337\/diabetes.46.6.941"},{"key":"2022031207372006600_R16","doi-asserted-by":"crossref","unstructured":"Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C: Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol\u2008141: 2625\u20132628,1988","DOI":"10.4049\/jimmunol.141.8.2625"},{"key":"2022031207372006600_R17","doi-asserted-by":"crossref","unstructured":"Seidel DK, Geiss HC, Donner MG, Ritter MM, Schwandt P, Koll RA, Standl E, Ziegler AG: Course of islet autoantibody titers during Ig-immunoadsorption in a patient with newly diagnosed type 1 diabetes. J Autoimmun\u200811: 273\u2013277,1998","DOI":"10.1006\/jaut.1998.0195"},{"key":"2022031207372006600_R18","doi-asserted-by":"crossref","unstructured":"Ludvigsson J, Heding L, Lieden G, Marner B, Lernmark A: Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J (Clin Res Ed)\u2008286: 176\u2013178,1983","DOI":"10.1136\/bmj.286.6360.176"},{"key":"2022031207372006600_R19","doi-asserted-by":"crossref","unstructured":"Forsgren S, Andersson A, Hillron V, Soderstrom A, Holmberg D: Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol\u200834: 445\u2013451,1991","DOI":"10.1111\/j.1365-3083.1991.tb01567.x"},{"key":"2022031207372006600_R20","doi-asserted-by":"crossref","unstructured":"Serreze DV, Chapman HD, Varnum DS, Hanson MS, Reifsnyder PC, Richard SD, Fleming SA, Leiter EH, Shultz LD: B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new \u201cspeed congenic\u201d stock of NOD.Ig mu null mice. J Exp Med\u2008184: 2049\u20132053,1996","DOI":"10.1084\/jem.184.5.2049"},{"key":"2022031207372006600_R21","doi-asserted-by":"crossref","unstructured":"Silveira PA, Johnson E, Chapman HD, Bui T, Tisch RM, Serreze DV: The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur J Immunol\u200832: 3657\u20133666,2002","DOI":"10.1002\/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E"},{"key":"2022031207372006600_R22","doi-asserted-by":"crossref","unstructured":"Warram JH, Krolewski AS, Gottlieb MS, Kahn CR: Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med\u2008311: 149\u2013152,1984","DOI":"10.1056\/NEJM198407193110304"},{"key":"2022031207372006600_R23","doi-asserted-by":"crossref","unstructured":"Pociot F, Norgaard K, Hobolth N, Andersen O, Nerup J: A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark: Danish Study Group of Diabetes in Childhood. Diabetologia\u200836: 870\u2013875,1993","DOI":"10.1007\/BF00400364"},{"key":"2022031207372006600_R24","doi-asserted-by":"crossref","unstructured":"Yu L, Chase HP, Falorni A, Rewers M, Lernmark A, Eisenbarth GS: Sexual dimorphism in transmission of expression of islet autoantibodies to offspring. Diabetologia\u200838: 1353\u20131357,1995","DOI":"10.1007\/BF00401769"},{"key":"2022031207372006600_R25","doi-asserted-by":"crossref","unstructured":"Kurts C, Sutherland RM, Davey G, Lew AM, Blanas E, Carbone F, Miller JFAP, Heath WR: CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A\u200896: 12703\u201312707,1999","DOI":"10.1073\/pnas.96.22.12703"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/53\/1\/1\/374782\/zdb00104000001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/53\/1\/1\/374782\/zdb00104000001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:52:10Z","timestamp":1683755530000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/53\/1\/1\/11630\/Transmission-of-Maternal-Islet-Antibodies-and-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.53.1.1","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,1]]}}}